Many and women head to the plastic surgeon’s office to get rid of wrinkles, tighten up loose skin and defy the aging process, but there may soon be another option.
According to results of a research study published by Randy Strong, PhD of the Aging Interventions Testing Center in San Antonio, a drug that was found in the soil of Easter Island in the South Pacific may be effective at slowing down the aging process.
Rapamycin has extended the life expectancy of middle-aged mice used to conduct the research by as much as 38%, and researchers believe that the drug may not only slow down the development of wrinkles and other signs of aging, but can also lower the risk of heart disease and certain types of cancer in humans. Rapamycin may be effective at postponing death from cancer, and slowing down several ageing processes that are linked to cell metabolism. According to a recent article in WebMD.com, rapamycin has immunosuppressant properties and is also being studied as a potential anticancer drug. Still, experts say it is too soon to believe that this drug can and will have a positive effect on humans.
The Aging Interventions Testing Center is funded by the National Institute of Aging, and the drug is the first to have shown a significant increase in life span in both male and female mice. The drug was delivered in a time-release formula that allowed for better absorption in the bloodstream. In the future, the drug may be combined with other drugs and medications in order to achieve desired results.
While more research and tests are required to determine if similar effects can be achieved in humans, researchers can now count on data that shows new molecular pathways for other drugs that may be effective in improving overall health and slowing down the ageing process.